Home » All » Stock Forecast » Acumen Pharmaceuticals Inc. Common Stock Forecast

Acumen Pharmaceuticals Inc. Common Stock Forecasts for Tomorrow, Week, Month and 5 Years

Updated: April 22 · 2026 at 07:03 UTC

From

▼ -3.87%Market Cap $197.14M · Technical analysis Bearish · Focus area Price + volatility

Forecast Summary

Timeframe	Predicted Price	Past	Historical	Insight
Tomorrow	$2.77 ▲ +1.41%	Yesterday	$2.71 ▼ -0.59%	Tomorrow's Acumen Pharmaceuticals Inc. Common Stock (ABOS) setup is anchored to $2.73 and targets $2.77 (+1.41%). The near-term read is upside; watch $2.81 / $2.65 because daily realized volatility is about 7.29%.
Tomorrow's Acumen Pharmaceuticals Inc. Common Stock (ABOS) setup is anchored to $2.73 and targets $2.77 (+1.41%). The near-term read is upside; watch $2.81 / $2.65 because daily realized volatility is about 7.29%.
Week	$2.85 ▲ +4.40%	Last Week	$2.68 ▼ -1.85%	The 7-day Acumen Pharmaceuticals Inc. Common Stock model moves from $2.68 to $2.85 (+4.40%). It gives upside momentum context for this stock, so breaks around $2.81 / $2.65 matter more than a single tick.
The 7-day Acumen Pharmaceuticals Inc. Common Stock model moves from $2.68 to $2.85 (+4.40%). It gives upside momentum context for this stock, so breaks around $2.81 / $2.65 matter more than a single tick.
Month	$2.99 ▲ +9.37%	Last Month	$2.62 ▼ -3.94%	The 1-month Acumen Pharmaceuticals Inc. Common Stock target is $2.99 (+9.37%), compared with the live reference near $2.73. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
The 1-month Acumen Pharmaceuticals Inc. Common Stock target is $2.99 (+9.37%), compared with the live reference near $2.73. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
Year	$3.19 ▲ +16.82%	Last Year	$2.54 ▼ -7.07%	The 1-year Acumen Pharmaceuticals Inc. Common Stock scenario points to $3.19 (+16.82%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
The 1-year Acumen Pharmaceuticals Inc. Common Stock scenario points to $3.19 (+16.82%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5 Years	$3.67 ▲ +34.29%	5 Years Ago	$2.34 ▼ -14.40%	The 5-year Acumen Pharmaceuticals Inc. Common Stock view is $3.67 (+34.29%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
The 5-year Acumen Pharmaceuticals Inc. Common Stock view is $3.67 (+34.29%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Tomorrow$2.77▲ +1.41%

Yesterday$2.71▼ -0.59%

Tomorrow's Acumen Pharmaceuticals Inc. Common Stock (ABOS) setup is anchored to $2.73 and targets $2.77 (+1.41%). The near-term read is upside; watch $2.81 / $2.65 because daily realized volatility is about 7.29%.

Week$2.85▲ +4.40%

Last Week$2.68▼ -1.85%

The 7-day Acumen Pharmaceuticals Inc. Common Stock model moves from $2.68 to $2.85 (+4.40%). It gives upside momentum context for this stock, so breaks around $2.81 / $2.65 matter more than a single tick.

Month$2.99▲ +9.37%

Last Month$2.62▼ -3.94%

The 1-month Acumen Pharmaceuticals Inc. Common Stock target is $2.99 (+9.37%), compared with the live reference near $2.73. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.

Year$3.19▲ +16.82%

Last Year$2.54▼ -7.07%

The 1-year Acumen Pharmaceuticals Inc. Common Stock scenario points to $3.19 (+16.82%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.

5 Years$3.67▲ +34.29%

5 Years Ago$2.34▼ -14.40%

The 5-year Acumen Pharmaceuticals Inc. Common Stock view is $3.67 (+34.29%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Risk notice:This forecast is informational only, not financial advice; accuracy depends on volatility, liquidity, macro events, and other external factors.

Price Chart

HistoricalForecastBullishBearish

Technical Analysis

Neutral

Bullish

Neutral

Bearish

Key Indicators

Indicator	Value	Signal
Price	$2.73	Mid
Daily Change	-3.87%	Below
Volatility Cap	20.0%	Mid
Confidence	66%	Above
Data Source	nasdaq-screener	Mid

Historical Data

Current$2.73

Daily Change-3.87%

Market Cap$197.14M

Sourcenasdaq-screener

Current	$2.73	Daily Change	-3.87%
Market Cap	$197.14M	Source	nasdaq-screener

Support & Resistance Levels

$2.65Support 1

$2.73Current

$2.81Resistance 1

Support and resistance are estimated from the trusted current price until deeper historical data is available.

Price Milestones

Key levels & historical context

Current$2.73Live reference price

Used as the anchor for generated forecast calculations.

Next Month$2.99Model projection+9.37%

Directional scenario based on capped drift.

Forecast Accuracy

How our model has performed

66%

Directional

Generated market-data forecast

This page uses live catalog market data and conservative volatility caps. It is informational, not financial advice.

📊

Our algorithm is re-calibrated weekly using the latest price action, volatility regime, and indicator signals. Accuracy varies by timeframe — short-term momentum is more reliable than long-term projections.

Short term

66%

Direction confidence

Long term

Lower

Forecast uncertainty rises with horizon

Investment Scenarios

If you invest $1,000 in ABOS today

Bullish Scenario

$2.87

+5.00% from current

Target Price$2.87

ScenarioUpside momentum

Probability58%

Base Scenario

$2.99

+9.37%

Target Price$2.99

ScenarioCapped drift

Probability66%

Bearish Scenario

$2.59

-5.00% from current

Target Price$2.59

ScenarioVolatility drawdown

Probability34%

Basis: Scenario model combines current spot price, recent market direction, and conservative asset-class volatility caps.

Forecast Factors

Market Structure

Price structure reflects the latest momentum regime and support/resistance interaction.

Momentum Bullish · 70/100

24H drift+1.41%

7D drift+4.40%

30D drift+9.37%

Technical Signals

Signals combine RSI, MACD, and moving average stacks to estimate short-term direction.

Mixed — Watching · 50/100

RSIn/a

MACDn/a

MA stackn/a

Macro Context

Rates, dollar strength, and cross-asset risk appetite influence medium-term paths.

Risk-On Tentative · 67/100

1M outlook+9.37%

1Y outlook+16.82%

5Y outlook+34.29%

Frequently Asked Questions

Q What is the Acumen Pharmaceuticals Inc. Common Stock (ABOS) forecast for tomorrow?

Using the latest BeCoin market snapshot (April 22 · 2026 at 07:03 UTC), Acumen Pharmaceuticals Inc. Common Stock is projected near $2.77 versus the current reference around $2.73. That implies a modeled move of +1.41% over the next day, with realized prices still sensitive to intraday volatility.

Q What does the 7-day stock outlook suggest for ABOS?

The weekly Acumen Pharmaceuticals Inc. Common Stock model points to $2.85, which maps to an expected drift of +4.40% from current conditions. This horizon reacts quickly to momentum shifts, so support/resistance breaks can change the path faster than long-term targets.

Q How should I read the Acumen Pharmaceuticals Inc. Common Stock 1-month and 1-year targets?

The Acumen Pharmaceuticals Inc. Common Stock 1-month target is $2.99 (+9.37%), while the 1-year target is $3.19 (+16.82%). The monthly view tracks prevailing trend pressure, and the yearly view reflects broader cycle assumptions shaped by price momentum, liquidity, and company-specific risk.

Q Why does the Acumen Pharmaceuticals Inc. Common Stock 5-year scenario differ from short-term rows?

The Acumen Pharmaceuticals Inc. Common Stock long-horizon scenario sits near $3.67 with a modeled change of +34.29%. It compounds cycle-continuation assumptions over time, so it should be treated as a scenario envelope rather than a precise endpoint.

Q Where are ABOS support and resistance zones right now?

For Acumen Pharmaceuticals Inc. Common Stock, nearest resistance is around $2.65, while nearest support is around $2.81. A clean break above resistance improves continuation odds, while repeated closes under support raise downside risk.

Q How fresh is the Acumen Pharmaceuticals Inc. Common Stock market snapshot?

The displayed stock snapshot is labeled April 22 · 2026 at 07:03 UTC; the latest observed session range is roughly n/a to n/a. These checkpoints are rebuilt from the market feed so the FAQ, milestones, and support/resistance context stay tied to the same data refresh.